Sign in
Taking people in United StatesNo phase

Turning off a gastric stimulator and its effect on insulin in gastroparesis

Tests how pausing a stomach stimulator changes insulin and sugar levels in gastroparesis.

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the site
Trial code
Registry title
Effect of Gastric Electrical Stimulation on Serum Insulin Levels
Status
Recruiting
People taking part
32 people, planned
Started
23 Jul 2026
Expected to end
31 Jul 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Gastric Electrical Stimulator
Record updated
1 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with gastroparesis (slow stomach emptying) who already have a gastric electrical stimulator (GES) implanted. It studies how turning the device off for up to four hours changes insulin, C-peptide, GLP-1 and glucose levels.

Age
18 years and older.
Sex
All sexes can join.
Disease stage
A documented diagnosis of gastroparesis. The condition list says nondiabetic gastroparesis.
Earlier treatment
A GES device must have been implanted for at least 3 months. People taking prescribed insulin for diabetes cannot join.

Main reasons for not taking part

  • Pregnancy
  • Past allergic reaction to the sticky pads used for EKG (heart tracing) leads
  • Not able to give informed consent
  • Not willing to give up to 8 blood samples of 5 ml
  • Not willing to lie in a bed for up to 5.5 hours

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • At least 18 years of age
  • Documented diagnosis of gastroparesis
  • Not taking diabetic prescribed exogenous insulin
  • Patient has a GES device that has been implanted for at least 3 months
  • Willing to give up to 8 blood samples
  • Willing to lie in a bed for up to 5.5 hours

Who cannot take part

  • History of allergic reaction to EKG lead placement adhesives
  • Pregnancy
  • Unable to give informed consent
  • Unwilling to give up to 8 5 ml blood samples
  • Unwilling to lie in a bed for up to 5.5 hours

Where in United States

  • Indiana University HospitalIndianapolis, United StatesContact: Maureen V Schilling, BSTaking people

About the trial

What the trial wants to find out

The goal of this study is to determine how much effect turning off an individual's Gastric Electrical Stimulator (GES) for up to four hours will have on levels of insulin, C-peptide, GLP-1 and glucose levels.

The 2 groups in the trial

  • The OFF GroupTreatment being tested

    This group of subjects will have their GES interrogated and observed as well as having the device turned off for the duration of the experiment. The device will then be re-interrogated and turned back on at the end of the experiment.

    Treatment: Gastric Electrical Stimulator

  • Control GroupNo study treatment, for comparison

    This group of subjects will undergo the same procedures as the experimental group, except that their GES will not be turned off during the experimental period.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Defining the Effect of Gastric Electrical Stimulation on Serum Insulin Levels in Human Subjects
Plain-language title
Turning off a gastric stimulator and its effect on insulin in gastroparesisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
1 October 2026